Harmony Biosciences Holdings
Ownership
Ownership Structure
Who owns Harmony Biosciences Holdings (HRMY)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 89.5% of the shares are freely tradable; institutional investors hold 103.5%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 12.20 | 7,101,965 | +0.5 | 06/30/2026 |
| FMR Inc | 6.14 | 3,574,115 | +13.2 | 06/30/2026 |
| Vanguard Portfolio Management, LLC | 4.95 | 2,880,489 | +6.1 | 06/30/2026 |
| American Century Companies Inc | 4.36 | 2,539,512 | +20.6 | 06/30/2026 |
| Dimensional Fund Advisors, Inc. | 4.11 | 2,393,588 | +15.3 | 06/30/2026 |
| Vanguard Capital Management, LLC | 3.61 | 2,105,053 | +0.1 | 06/30/2026 |
| LSV Asset Management | 3.54 | 2,061,242 | +1.8 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 5.06 | 2,946,365 | +0.0 | 09/30/2026 |
| Avantis US Small Cap Value ETF | 4.53 | 2,635,361 | +0.2 | 09/30/2026 |
| HBM Healthcare Investments AG Ord | 3.69 | 2,147,943 | +0.0 | 06/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Budur Kumar | CHIEF MEDICAL OFFICER | 13,115 | 485,255 $ | Sep 18, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 18, 2026 | Budur Kumar | CHIEF MEDICAL OFFICER | Sell | 35,852 | 43.05 | 1,543,590 |
| Sep 18, 2026 | Budur Kumar | CHIEF MEDICAL OFFICER | Other | 25,446 | 30.27 | 770,250 |
| Sep 18, 2026 | Budur Kumar | CHIEF MEDICAL OFFICER | Other | 10,406 | 30.69 | 319,360 |
| Sep 17, 2026 | Budur Kumar | CHIEF MEDICAL OFFICER | Sell | 800 | 43.00 | 34,400 |
| Sep 17, 2026 | Budur Kumar | CHIEF MEDICAL OFFICER | Other | 400 | 30.27 | 12,108 |
| Sep 16, 2026 | Budur Kumar | CHIEF MEDICAL OFFICER | Sell | 1,800 | 43.01 | 77,426 |
| Sep 16, 2026 | Budur Kumar | CHIEF MEDICAL OFFICER | Other | 900 | 30.27 | 27,243 |
| Sep 8, 2026 | Budur Kumar | CHIEF MEDICAL OFFICER | Sell | 22,954 | 43.10 | 989,350 |
| Sep 8, 2026 | Budur Kumar | CHIEF MEDICAL OFFICER | Other | 10,754 | 30.27 | 325,524 |
| Sep 8, 2026 | Budur Kumar | CHIEF MEDICAL OFFICER | Other | 12,200 | 30.69 | 374,418 |
| Sep 8, 2026 | Budur Kumar | CHIEF MEDICAL OFFICER | Sell | 1,000 | 42.79 | 42,795 |
| Sep 8, 2026 | Budur Kumar | CHIEF MEDICAL OFFICER | Sell | 4,500 | 42.25 | 190,114 |
| Sep 4, 2026 | Budur Kumar | CHIEF MEDICAL OFFICER | Sell | 5,500 | 41.98 | 230,911 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: November 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.